PMID- 7811465 OWN - NLM STAT- MEDLINE DCOM- 19950209 LR - 20181130 IS - 1044-1549 (Print) IS - 1044-1549 (Linking) VI - 12 IP - 1 DP - 1995 Jan TI - Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta. PG - 104-9 AB - Chemotactic cytokines coordinate the recruitment of leukocytes into the lung during pulmonary inflammation. In a previous study, we determined that rat pulmonary alveolar macrophages (PAMs) facilitate monocyte recruitment and activation in the lung during acute inflammatory lung injury, in part, through the inducible expression of monocyte chemoattractant protein-1 (MCP-1). MCP-1 is an 11 to 15 kD basic peptide that specifically mediates monocyte chemotaxis and activation. Inflammatory mediators that regulate the expression and secretion of MCP-1 by rat PAMs have not been identified. We determined that stimulation of resident rat PAMs with bacterial lipopolysaccharide (LPS), murine tumor necrosis factor-alpha, or human interleukin-1 beta resulted in the inducible expression of MCP-1 mRNA and the secretion of biologically active MCP-1. In contrast, phorbol myristate acetate, a nonphysiologic leukocyte activator, was significantly less effective in stimulating either enhanced MCP-1 mRNA expression or secretion of MCP-1. These results indicate that the expression of MCP-1 mRNA and the secretion of MCP-1 by rat PAMs are regulated by bacterial products (LPS) and inflammatory cytokines. Further, these results suggest PAMs are regulated by bacterial products (LPS) and inflammatory cytokines. Further, these results suggest that resident PAMs, through elaboration of MCP-1, may play a pivotal role in regulating recruitment and activation of monocytes in the lung during acute inflammatory lung injury. FAU - Brieland, J K AU - Brieland JK AD - Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor 48109-0614. FAU - Flory, C M AU - Flory CM FAU - Jones, M L AU - Jones ML FAU - Miller, G R AU - Miller GR FAU - Remick, D G AU - Remick DG FAU - Warren, J S AU - Warren JS FAU - Fantone, J C AU - Fantone JC LA - eng GR - HL-49136/HL/NHLBI NIH HHS/United States GR - RR-00200/RR/NCRR NIH HHS/United States GR - RR-07008/RR/NCRR NIH HHS/United States GR - etc. PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Respir Cell Mol Biol JT - American journal of respiratory cell and molecular biology JID - 8917225 RN - 0 (Alkaloids) RN - 0 (Chemokine CCL2) RN - 0 (Chemotactic Factors) RN - 0 (Interleukin-1) RN - 0 (Lipopolysaccharides) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.11.13 (Protein Kinase C) RN - H88EPA0A3N (Staurosporine) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Alkaloids/pharmacology MH - Animals MH - Base Sequence MH - Chemokine CCL2 MH - Chemotactic Factors/*genetics/metabolism MH - Chemotaxis, Leukocyte MH - Gene Expression Regulation/*drug effects MH - Interleukin-1/*pharmacology MH - Lipopolysaccharides/*pharmacology MH - Macrophage Activation MH - Macrophages, Alveolar/drug effects/*metabolism MH - Male MH - Molecular Sequence Data MH - Protein Kinase C/antagonists & inhibitors/physiology MH - RNA, Messenger/biosynthesis MH - Rats MH - Specific Pathogen-Free Organisms MH - Staurosporine MH - Tetradecanoylphorbol Acetate/pharmacology MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 1995/01/01 00:00 MHDA- 1995/01/01 00:01 CRDT- 1995/01/01 00:00 PHST- 1995/01/01 00:00 [pubmed] PHST- 1995/01/01 00:01 [medline] PHST- 1995/01/01 00:00 [entrez] AID - 10.1165/ajrcmb.12.1.7811465 [doi] PST - ppublish SO - Am J Respir Cell Mol Biol. 1995 Jan;12(1):104-9. doi: 10.1165/ajrcmb.12.1.7811465.